Calendar Cartesian Therapeutics, Inc.

Equities

RNAC

US8162123025

Market Closed - Nasdaq 04:00:00 2024-05-22 pm EDT 5-day change 1st Jan Change
25.46 USD +3.50% Intraday chart for Cartesian Therapeutics, Inc. -4.47% +23.10%

Chart calendar Cartesian Therapeutics, Inc.

8e661948162.atywy3MTchOQLGKlxDLvU7kticUXRkuO3KJu4dTJjAU.OZ3xrScnAlzaGRT8lkWNDIsVzpxIMR_i5fgtlLWg6TIZkfSpA2JEUNR6Vg~1ddb1407c94e36734cea4df637eb31c6

Upcoming events on Cartesian Therapeutics, Inc.

2024-06-14 10:00 am Annual General Meeting

Past events on Cartesian Therapeutics, Inc.

2024-05-20 03:00 pm H.C. Wainwright BioConnect Investor Conference
2024-05-10 01:45 pm American Society of Gene & Cell Therapy Meeting - Abstract Number: 241
2024-05-08 07:00 am Q1 2024 Earnings Release
2024-04-09 03:00 pm Needham Healthcare Conference
2024-03-27 09:00 am Extraordinary Shareholders Meeting
2024-03-26 11:00 am H.C. Wainwright Cell Therapy Virtual Conference
2024-03-13 08:40 am Leerink Partners Global Biopharma Conference
2024-03-07 07:00 am Q4 2023 Earnings Release
2023-08-17 08:30 am Q2 2023 Earnings Call
2023-08-17 07:00 am Q2 2023 Earnings Release
2023-06-16 10:00 am Annual General Meeting
2023-05-30 European Alliance of Associations for Rheumatology European Congress
2023-05-04 08:30 am Q1 2023 Earnings Call
2023-05-04 07:30 am Q1 2023 Earnings Release
2023-03-21 08:30 am DISSOLVE I & II SEL-212 Phase 3 Trail Results Call
2023-03-02 08:30 am Q4 2022 Earnings Call
2023-03-01 Q4 2022 Earnings Release
2023-02-14 08:00 am SVB Securities Global Biopharma Conference
2022-11-14 01:35 pm Immunology & Neurology Day
2022-11-03 08:30 am Q3 2022 Earnings Call

Annual results

Fiscal PeriodDecember 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


26,0
10,6
145.32%

5,83

EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
0,00


-86,4
-14,3
-506.39%

-53,6

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-6,46


-239
-13,7
-1645.21%

-91,3

Net income
Million USD
Released
Forecast
Spread
-6,46


-220
-13,7
-1506.3%

-100

EPS
USD
Released
Forecast
Spread
0,00


-49,8
-0,60
-8200.01%

-10,3

Announcement Date23/01/2407/03/24-

Quarterly results

Fiscal PeriodDecember 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread

2,50

5,84
0,00
-

0,00


0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread

-6,00

-13,3
-8,63
-54.76%

-12,8


-13,6


-13,9


-14,8


-15,1

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread

-5,91

-56,8
-6,29
-803.55%

-10,7


-11,6


-12,2


-13,1


-14,0

Net income
Million USD
Released
Forecast
Spread

-5,91

-56,8
-8,14
-597.7%

-13,4


-14,9


-15,2


-14,3


-14,7

EPS
USD
Released
Forecast
Spread

-0,30

-10,5
-0,35
-2900%

-1,38


-1,33


-1,30


-1,70


-1,70

Announcement Date-08/05/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. RNAC Stock
  4. Calendar Cartesian Therapeutics, Inc.